Profile data is unavailable for this security.
About the company
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
- Revenue in DKK (TTM)407.87m
- Net income in DKK136.28m
- Incorporated1997
- Employees173.00
- LocationChemometec A/SGydevang 43ALLEROED 3450DenmarkDNK
- Websitehttps://chemometec.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sedana Medical AB (publ) | 110.77m | -27.23m | 1.53bn | 81.00 | -- | 2.40 | -- | 13.84 | -0.4175 | -0.4175 | 1.70 | 9.79 | 0.1609 | 1.19 | 10.82 | 2,135,139.00 | -3.95 | -5.77 | -4.17 | -6.08 | 70.32 | 64.06 | -24.59 | -36.13 | 5.66 | -- | 0.0081 | -- | 25.23 | 21.59 | 18.90 | -- | 42.12 | -- |
BICO Group AB | 1.48bn | -516.71m | 2.00bn | 828.00 | -- | 1.05 | -- | 1.35 | -11.15 | -15.20 | 31.92 | 41.79 | 0.3602 | 2.15 | 4.47 | 2,547,964.00 | -12.62 | -- | -14.44 | -- | 55.70 | -- | -35.03 | -- | 2.23 | -0.5705 | 0.397 | -- | 6.09 | -- | -1,889.33 | -- | -- | -- |
Detection Technology Oyj | -745.82bn | -745.82bn | 2.02bn | 464.00 | -- | 3.66 | -- | -- | -- | -- | -- | 5.03 | -- | -- | -- | -- | -- | 9.34 | -- | 11.96 | -- | 47.44 | -- | 8.22 | 3.39 | -- | 0.00 | 53.45 | 5.29 | 2.02 | 7.55 | -18.03 | -14.88 | -9.55 |
Medistim ASA | 343.24m | 66.52m | 2.10bn | 152.00 | 31.58 | 8.60 | 25.49 | 6.13 | 5.70 | 5.70 | 29.41 | 20.93 | 1.17 | 0.7319 | 6.34 | 3,542,250.00 | 22.71 | 22.93 | 27.59 | 28.52 | 79.49 | 78.25 | 19.38 | 20.64 | 2.40 | -- | 0.0262 | 75.25 | 7.00 | 10.06 | -8.91 | 12.72 | 0.033 | 14.87 |
RaySearch Laboratories AB (publ) | 741.17m | 99.31m | 2.86bn | 403.00 | 37.06 | 7.29 | 10.36 | 3.86 | 4.41 | 4.41 | 32.91 | 22.41 | 0.5701 | 4.50 | 3.11 | 2,901,244.00 | 7.64 | 1.29 | 11.80 | 1.88 | 90.48 | 90.57 | 13.40 | 2.55 | 1.17 | -- | 0.3937 | 69.00 | 21.16 | 10.26 | 243.06 | 0.7648 | -1.31 | -- |
Surgical Science Sweden AB | 550.50m | 129.85m | 4.08bn | 265.00 | 31.44 | 1.35 | 24.34 | 7.41 | 3.87 | 3.87 | 16.43 | 90.02 | 0.1695 | 1.49 | 7.35 | 3,224,027.00 | 4.00 | 4.49 | 4.26 | 4.78 | 68.51 | 70.06 | 23.59 | 23.75 | 3.46 | -- | 0.00 | 0.00 | 10.01 | 68.14 | 24.47 | -- | 38.57 | -- |
CellaVision AB | 477.04m | 95.26m | 4.40bn | 221.00 | 46.20 | 9.07 | 35.94 | 9.23 | 6.08 | 6.08 | 30.45 | 31.00 | 0.783 | 1.76 | 6.66 | 3,185,965.00 | 15.64 | 15.30 | 18.18 | 18.24 | 66.62 | 69.03 | 19.97 | 19.98 | 1.99 | 103.58 | 0.0574 | 110.18 | 5.94 | 13.17 | 10.12 | 8.00 | 30.45 | 8.45 |
Revenio Group Oyj | 721.03m | 141.77m | 6.82bn | 216.00 | 47.55 | 9.12 | 39.82 | 9.46 | 0.7205 | 0.7205 | 3.66 | 3.76 | 0.7069 | 5.50 | 7.60 | 447,574.10 | 13.90 | 14.33 | 16.77 | 17.90 | 51.01 | 50.73 | 19.66 | 21.13 | 1.79 | 28.49 | 0.1521 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
Arjo AB (publ) | 7.37bn | 352.00m | 7.33bn | 6.94k | 22.31 | 1.50 | 7.21 | 0.994 | 1.97 | 1.97 | 41.21 | 29.20 | 0.6957 | 4.40 | 6.51 | 1,651,221.00 | 3.31 | 3.55 | 4.51 | 5.55 | 43.68 | 44.01 | 4.76 | 5.41 | 0.6657 | 4.01 | 0.4123 | 43.01 | 10.03 | 5.97 | 6.90 | 10.15 | -8.89 | 10.35 |
ChemoMetec A/S | 407.87m | 136.28m | 7.48bn | 173.00 | 54.91 | 13.24 | 48.59 | 18.35 | 7.83 | 7.83 | 23.44 | 32.48 | 0.6112 | 0.745 | 6.97 | 2,357,630.00 | 20.42 | 27.96 | 24.40 | 35.10 | 78.80 | 79.57 | 33.41 | 35.02 | 3.76 | -- | 0.0073 | 144.08 | -8.22 | 18.37 | -23.72 | 26.64 | 9.97 | -11.81 |
Biotage AB | 1.37bn | 164.18m | 9.48bn | 667.00 | 57.78 | 3.81 | 33.27 | 6.92 | 3.12 | 3.12 | 26.05 | 47.36 | 0.4237 | 1.70 | 6.60 | 3,094,956.00 | 5.08 | 10.74 | 5.87 | 12.77 | 62.90 | 61.40 | 11.98 | 15.75 | 1.14 | 16.13 | 0.0628 | 40.11 | 19.54 | 15.50 | -8.21 | 7.97 | 14.05 | 1.30 |
Xvivo Perfusion AB | 458.87m | 79.29m | 10.63bn | 152.00 | 130.24 | 8.00 | 85.46 | 23.17 | 3.95 | 3.95 | 22.69 | 64.28 | 0.3441 | 1.22 | 4.48 | 4,367,031.00 | 5.95 | 1.24 | 6.45 | 1.33 | 74.16 | 73.14 | 17.28 | 4.76 | 3.27 | -- | 0.0133 | 0.00 | 43.88 | 26.04 | 398.29 | 48.57 | 21.35 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Investment Management (UK) Ltd.as of 31 Aug 2024 | 1.69m | 9.73% |
Invesco Advisers, Inc.as of 16 May 2023 | 881.14k | 5.06% |
Fj�rde AP-fondenas of 30 Jun 2024 | 597.30k | 3.43% |
Swedbank Robur Fonder ABas of 30 Aug 2024 | 575.00k | 3.30% |
The Vanguard Group, Inc.as of 04 Sep 2024 | 571.14k | 3.28% |
SEB Investment Management AB (Denmark)as of 30 Aug 2024 | 569.43k | 3.27% |
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 28 Jun 2024 | 519.92k | 2.99% |
Handelsbanken Fonder ABas of 31 Aug 2024 | 518.08k | 2.98% |
Fidelity Management & Research Co. LLCas of 31 Jul 2024 | 430.38k | 2.47% |
Norges Bank Investment Managementas of 31 Dec 2023 | 411.11k | 2.36% |